Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
Front Pharmacol
.
2021 Apr 12:12:631646.
doi: 10.3389/fphar.2021.631646.
eCollection 2021.
Authors
Maurizio Bifulco
1
,
Donatella Fiore
2
,
Chiara Piscopo
2
,
Patrizia Gazzerro
2
,
Maria Chiara Proto
2
Affiliations
1
Department of Molecular Medicine and Medical Biotechnologies, University of Naples "Federico II", Naples, Italy.
2
Department of Pharmacy, University of Salerno, Fisciano, Italy.
PMID:
33912048
PMCID:
PMC8072334
DOI:
10.3389/fphar.2021.631646
No abstract available
Keywords:
ARDS; COVID–19; SARS–CoV–2; cannabidiol; cannabinoids; pneumonia.
Publication types
Comment